Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

MYCOBUTIN® Principal Display Panel (rifabutin)

PRINCIPAL DISPLAY PANEL - 150 mg Capsule Bottle Label

NDC 0013-5301-17

(rifabutin) capsules, USP

150 mg

100 Capsules
Rx only

PRINCIPAL DISPLAY PANEL - 150 mg Capsule Bottle Label
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event